Correction: High expression of HMGA2 independently predicts poor clinical outcomes in acute myeloid leukemia (Blood Cancer Journal, (2018), 8, 8, (68), 10.1038/s41408-018-0103-6)

Miriam Marquis, Cyrielle Beaubois, Vincent Philippe Lavallée, Michal Abrahamowicz, Coraline Danieli, Sébastien Lemieux, Imran Ahmad, Andrew Wei, Stephen B. Ting, Shaun Fleming, Anthony Schwarer, David Grimwade, William Grey, Robert K. Hills, Paresh Vyas, Nigel Russell, Guy Sauvageau, Josée Hébert

Research output: Contribution to journalComment / DebateOtherpeer-review

Abstract

Since the publication of the original article the authors noticed the the affiliation details for Paresh Vyas are incorrect.

Original languageEnglish
Article number28
Number of pages1
JournalBlood Cancer Journal
Volume9
Issue number3
DOIs
Publication statusPublished - 1 Mar 2019

Cite this

Marquis, M., Beaubois, C., Lavallée, V. P., Abrahamowicz, M., Danieli, C., Lemieux, S., Ahmad, I., Wei, A., Ting, S. B., Fleming, S., Schwarer, A., Grimwade, D., Grey, W., Hills, R. K., Vyas, P., Russell, N., Sauvageau, G., & Hébert, J. (2019). Correction: High expression of HMGA2 independently predicts poor clinical outcomes in acute myeloid leukemia (Blood Cancer Journal, (2018), 8, 8, (68), 10.1038/s41408-018-0103-6). Blood Cancer Journal, 9(3), [28]. https://doi.org/10.1038/s41408-019-0190-z